85 related articles for article (PubMed ID: 1306981)
1. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
Hirano T; Manabe T; Ohshio G; Nio Y
Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat.
Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J
J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T
Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415
[TBL] [Abstract][Full Text] [Related]
5. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of gabexate mesilate (FOY) against pancreatic injuries induced by ethanol in rats.
Hirano T
Nihon Geka Hokan; 1994 Jan; 63(1):10-20. PubMed ID: 7826181
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin attenuates the development of acute pancreatitis in rat.
Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
[TBL] [Abstract][Full Text] [Related]
10. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis.
Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T
Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311
[TBL] [Abstract][Full Text] [Related]
11. IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis.
Warzecha Z; Dembinski A; Ceranowicz P; Konturek SJ; Tomaszewska R; Stachura J; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):575-90. PubMed ID: 14726612
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist.
Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K
J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504
[TBL] [Abstract][Full Text] [Related]
13. The role of adenosine receptors for pancreatic blood flow in caerulein-induced acute pancreatitis.
Celiński K; Szczerbiński M; Słomka M; Kasztelan-Szczerbińska B
Rocz Akad Med Bialymst; 2003; 48():57-60. PubMed ID: 14737942
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
15. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930
[TBL] [Abstract][Full Text] [Related]
16. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
Hirano T; Manabe T; Tobe T
J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-derived free radicals and acute pancreatitis: a review.
Sanfey H; Sarr MG; Bulkley GB; Cameron JL
Acta Physiol Scand Suppl; 1986; 548():109-18. PubMed ID: 3529821
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats.
Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T
Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235
[TBL] [Abstract][Full Text] [Related]
19. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein.
Hirano T; Manabe T; Tobe T
Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
